Analyte has an impressive track record of innovation.
Chicago, IL (PRWEB) July 26, 2012
TechNexus, Chicago’s first incubator for tech entrepreneurs and business leaders, congratulates Analyte Health on its recent round of funding. Analyte is one of more than 170 startups and young companies that have spent formative time growing inside TechNexus since 2007. Analyte announced Wednesday a Series C round of venture capital funding, bringing the company’s total funding up to $22 million.
Analyte Health, founded in 2007 and based in Chicago, creates Web portals to serve as online clinics that pair expert information with quality care for millions of Americans.
Analyte has said it plans to use the funds to expand its product line and bolster marketing efforts. Analyte’s investors include Apex Venture Partners, New World Ventures and Mohr Davidow Ventures.
“Analyte has an impressive track record of innovation,” said Terry Howerton, managing partner of TechNexus. “They’ve made great strides as a leader in connecting online health information and real-world physical care.”
Analyte Health was a collaborator in the TechNexus space from 2007 to 2009, and the company has since grown to 70 employees.
For more information about Analyte Health, visit http://www.analytehealth.com.
TechNexus is a startup incubator and gateway to collaboration and growth for Chicago’s technology and business leaders. Established in 2007, the ecosystem is funded privately and is anchored around the Illinois Technology Association (ITA) and nearly 75 other community groups. In 2012 TechNexus was recognized as one of America’s top 10 business incubators by Forbes Magazine. TechNexus is a ‘clubhouse’ where ventures grow, and a co-working facility to bring technology professionals together, foster relationships and promote a sense of community. For more information, visit http://www.technexus.com.